Cohen Cheryl

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 34% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cohen Cheryl's trades of ImmunityBio, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
399.47
Quantity 5,291 -14.1%
Value US$4,577,241
Transaction date
Proposed sale
Price
411.01
Quantity 25,381
Value US$4,376,174
Transaction date
Planned sale
Price
466.18
Quantity 98,537 +50.0%
Value US$1,709,465
Transaction date
Proposed sale
Price
9.20
Quantity 131,210
Value US$1,207,132
Transaction date
Sale
Price
9.96
Quantity 30,000 -10.0%
Value US$298,785
US Immunic Inc (IMUX)
Transaction date
Sale
Price
0.55
Quantity 3,500 -100.0%
Value US$1,925
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-06 2026-10-02
PlS Planned sale
5,291 -14.1%
399.47
US$4,577,241 		5,291 -14.1% 399.47 US$4,577,241
2026-10-02 2026-10-02
PrS Proposed sale
25,381
411.01
US$4,376,174 		25,381 411.01 US$4,376,174
2026-07-06 2026-07-02
PlS Planned sale
98,537 +50.0%
466.18
US$1,709,465 		98,537 +50.0% 466.18 US$1,709,465
2026-07-02 2026-07-02
PrS Proposed sale
131,210
9.20
US$1,207,132 		131,210 9.20 US$1,207,132
2020-08-13 2020-08-11
S Sale
30,000 -10.0%
9.96
US$298,785 		30,000 -10.0% 9.96 US$298,785
2018-09-14 2018-09-12
US Immunic Inc (IMUX)
S Sale
3,500 -100.0%
0.55
US$1,925 		3,500 -100.0% 0.55 US$1,925